Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
250.50    5.50 (2.24%)
Bid:
250.00
Ask:
251.00
Spread: 1.00 (0.40%)
Market Cap: £146.13m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Director/PDMR Shareholding

18 Oct 2024 16:19

RNS Number : 8324I
MJ Gleeson PLC
18 October 2024
 

MJ GLEESON plc

Incorporated in England and Wales

Registration number: 09268016

LEI: 21380064K7N2W7FD6434

ISIN: GB00BRKD9Z53

 

 

18 October 2024

 

MJ Gleeson plc ("Gleeson" or the "Company")

 

Exercise of Options and Director/PDMR Dealing

 

The Company announces that on 17 October 2024, James Thomson and Stefan Allanson, Chairman and Chief Financial Officer respectively, exercised share options over 57,935 ordinary shares of 2 pence each in the capital of the Company ("Ordinary Shares"). The share options were granted under the Company's Annual and Deferred Bonus Plan in respect of bonuses earned for the year ended 30 June 2022. The share options will be satisfied with Ordinary Shares held within the Company's Employee Benefit Trust.

 

Subsequent to the exercise of the share options, Stefan Allanson has sold 10,532 ordinary shares at an average price of 620 pence per Ordinary Share in order to satisfy tax liabilities resulting from the exercise of the abovementioned options.

 

Following the completion of the exercise and the sale, the aggregate shareholdings of James Thomson and Stefan Allanson will be:

 

Name

Aggregate shareholding (Ordinary Shares)

Percentage of total voting rights

James Thomson

112,518

0.193%

Stefan Allanson

169,400

0.290%

 

 

Enquiries:

 

MJ Gleeson plc Tel: 44 1142 612 900

Leanne Johnson Company Secretary

 

LEI: 21380064K7N2W7FD6434

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

James Thomson

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chairman

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

MJ Gleeson plc

b)

 

LEI

 

 

21380064K7N2W7FD6434

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 2 pence each

Identification code

ISIN: GB00BRKD9Z53

b)

 

Nature of the transaction

 

 

Exercise of Options into Shares

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Nil (exercise of options)

35,594

d)

 

Aggregated information

- Aggregated volume

n/a

- Price

e)

 

Date of the transaction

 

 

17 October 2024

f)

 

Place of the transaction

 

Off market

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Stefan Allanson

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

MJ Gleeson plc

b)

 

LEI

 

 

21380064K7N2W7FD6434

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 2 pence each

Identification code

ISIN: GB00BRKD9Z53

b)

 

Nature of the transaction

 

 

1) Exercise of Options into Shares

2) Sale of Ordinary Shares

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

1) Nil (exercise of options)

2) 620 pence

1) 22,341

 

2) 10,532

d)

 

Aggregated information

- Aggregated volume

n/a

- Price

e)

 

Date of the transaction

 

 

17 October 2024

f)

 

Place of the transaction

 

1) Off market

2) London Stock Exchange (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHMPBATMTBBBRI
Date   Source Headline
2nd Jun 20267:00 amRNSBoard Committee Changes
7th May 20264:36 pmRNSDirector/PDMR Shareholding
7th May 20262:49 pmRNSDirector/PDMR Shareholding
1st May 20267:00 amRNSTrading Update
23rd Apr 20267:00 amRNSNotice of Trading Updates and FY2026 Results
14th Apr 20269:34 amRNSDirector/PDMR Shareholding
14th Apr 20269:33 amRNSDirector/PDMR Shareholding
6th Mar 20263:19 pmRNSDirector/PDMR Shareholding
2nd Mar 20264:04 pmRNSHolding(s) in Company
11th Feb 20267:00 amRNSResults for the half year ended 31 December 2025
9th Feb 202610:47 amRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNS-RPresentation of HY Results on Engage Investor
16th Jan 20267:00 amRNSTrading Update and Notice of Results
6th Jan 20264:40 pmRNSDirector/PDMR Shareholding
9th Dec 202511:31 amRNSDirector/PDMR Shareholding
25th Nov 20251:01 pmRNSDirector/PDMR Shareholding
20th Nov 20253:25 pmRNSHolding(s) in Company
14th Nov 20252:46 pmRNSResult of AGM
14th Nov 20257:01 amRNSAppointment of Non-Executive Director
14th Nov 20257:00 amRNSAGM Trading Update
6th Nov 20255:09 pmRNSDirector/PDMR Shareholding
24th Oct 20254:16 pmRNSDirector/PDMR Shareholding
23rd Oct 20255:07 pmRNSDirector/PDMR Shareholding
20th Oct 20254:09 pmRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSNotice of AGM
7th Oct 20253:18 pmRNSDirector/PDMR Shareholding
22nd Sep 20255:01 pmRNSREPLACEMENT: Director/PDMR Shareholding
18th Sep 20257:00 amRNS-RPresentation on Engage Investor Platform
17th Sep 20254:23 pmRNSDirector/PDMR Shareholding
16th Sep 20257:00 amRNSAudited results for the year ended 30 June 2025
9th Sep 202510:45 amRNSDirector/PDMR Shareholding
13th Aug 20257:00 amRNSNotice of Full-Year Results and Presentation
7th Aug 20253:05 pmRNSDirector/PDMR Shareholding
10th Jul 20254:17 pmRNSDirector/PDMR Shareholding
9th Jul 20251:05 pmRNSHolding(s) in Company
8th Jul 20254:00 pmRNSDirector/PDMR Shareholding
7th Jul 20253:11 pmRNSHolding(s) in Company
4th Jul 20257:00 amRNSDirectorate Change
4th Jul 20257:00 amRNSTrading Statement
12th Jun 20253:21 pmRNSDirector/PDMR Shareholding
10th Jun 202511:34 amRNSDirector/PDMR Shareholding
6th Jun 20257:00 amRNSHolding(s) in Company
4th Jun 20255:06 pmRNSDirector/PDMR Shareholding
3rd Jun 20257:03 amRNSTrading Update
7th May 20252:33 pmRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSDirectorate Change
8th Apr 20255:22 pmRNSDirector/PDMR Shareholding
8th Apr 20255:17 pmRNSDirector/PDMR Shareholding
6th Mar 20254:52 pmRNSDirector/PDMR Shareholding
5th Mar 20252:54 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.